openPR Logo
Press release

Postoperative Pain Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

11-10-2022 12:26 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Postoperative Pain Pipeline Drugs and Companies Insight Report

Postoperative Pain pipeline constitutes 55+ key companies continuously working towards developing 55+ Postoperative Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

Postoperative Pain Overview
Postoperative pain is an anticipated and temporary pain that occurs following grafting procedures or burn excision. Postoperative pain is experienced by the vast majority of patients who undergo surgical procedures. Control of postoperative pain plays an essential role in facilitating a patient's recovery to normal function and reduces the incidence of adverse physiologic and psychological effects associated with acute, uncontrolled pain. Postoperative pain control may be achieved by a variety of mechanisms, including (but not limited to) the use of pharmacological agents and interventional techniques.

"Postoperative Pain Pipeline Insight, 2022" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Postoperative Pain Market.

The Postoperative Pain Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Postoperative Pain Pipeline Report: https://www.delveinsight.com/report-store/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Companies across the globe are diligently working toward developing novel Postoperative Pain treatment therapies with a considerable amount of success over the years. Postoperative Pain Key players such as - Allay Therapeutics, Antibe Therapeutics, Pharmaleads, Flexion Therapeutics, RHNano pharma, SiteOne Therapeutics, LipoCure, Nevakar, Jiangsu Hengrui Medicine, Novartis, Cytogel Pharma, Farmaceutica S.A., Vivozon, Sichuan Haisco Pharmaceutical, and others, are developing therapies for the Postoperative Pain treatment
Postoperative Pain Emerging therapies such as - ATX-201, ATB-352, PL37, FX301, RHN-002, ST-2427, LC-400, NVK009, HR-021618, SAF312, CYT-1010, APSCTC, VVZ-149, HSK 21542, and others are expected to have a significant impact on the Postoperative Pain market in the coming years.
In May 2020, Axxam S.p.A. announced a collaboration with Vivozon Inc. with the aim to support Vivozon in the development of innovative small molecule drugs for the treatment of patients with unmet CNS medical needs.
In June 2020, Vivozon initiated a Phase III, multicenter, randomized, double-blind, parallel group, Placebo controlled study to evaluate the efficacy and safety of VVZ-149 injections for the treatment of postoperative pain following bunionectomy.

Postoperative Pain Pipeline Therapeutics Assessment
Postoperative Pain Assessment by Product Type
Postoperative Pain By Stage and Product Type
Postoperative Pain Assessment by Route of Administration
Postoperative Pain By Stage and Route of Administration
Postoperative Pain Assessment by Molecule Type
Postoperative Pain by Stage and Molecule Type

DelveInsight's Postoperative Pain Report covers around 55+ products under different phases of clinical development like
Late-stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I)
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Route of Administration

Emerging Postoperative Pain Drugs Under Different Phases of Clinical Development Include:
ATX-201: Allay Therapeutics
ATB-352: Antibe Therapeutics
PL37: Pharmaleads
FX301: Flexion Therapeutics
RHN-002: RHNano pharma
ST-2427: SiteOne Therapeutics
LC-400: LipoCure
NVK009: Nevakar
HR-021618: Jiangsu Hengrui Medicine
SAF312: Novartis
CYT-1010: Cytogel Pharma
APSCTC: Farmaceutica S.A.
VVZ-149: Vivozon
HSK 21542: Sichuan Haisco Pharmaceutical

Get a Free Sample PDF Report to know more about Postoperative Pain Pipeline Assessment- https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Postoperative Pain Pipeline Analysis:
The Postoperative Pain pipeline report provides insights into
The report provides detailed insights about companies that are developing therapies for the Postoperative Pain treatment with aggregate therapies developed by each company for the same.
It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Postoperative Pain Treatment.
Postoperative Pain key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Postoperative Pain Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Postoperative Pain market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Postoperative Pain product details are provided in the report. Download the Postoperative Pain pipeline report to learn more about the emerging Postoperative Pain therapies at:
https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Postoperative Pain Pipeline Market Drivers
Rise in the number of surgical procedures
Innovations in pain management, drug discovery and development
Government's initiative to promote better postoperative pain treatment

Postoperative Pain Pipeline Market Barriers
Adverse effects associated with the medications
Research Gaps in Practice Guidelines for Acute Postoperative Pain Management
Age-specific Postoperative Pain Treatment

Scope of Postoperative Pain Pipeline Drug Insight
Coverage: Global
Key Postoperative Pain Companies: Allay Therapeutics, Antibe Therapeutics, Pharmaleads, Flexion Therapeutics, RHNano pharma, SiteOne Therapeutics, LipoCure, Nevakar, Jiangsu Hengrui Medicine, Novartis, Cytogel Pharma, Farmaceutica S.A., Vivozon, Sichuan Haisco Pharmaceutical, and others
Key Postoperative Pain Therapies: ATX-201, ATB-352, PL37, FX301, RHN-002, ST-2427, LC-400, NVK009, HR-021618, SAF312, CYT-1010, APSCTC, VVZ-149, HSK 21542, and others
Postoperative Pain Therapeutic Assessment: Postoperative Pain current marketed and Postoperative Pain emerging therapies
Postoperative Pain Market Dynamics: Postoperative Pain market drivers and Postoperative Pain market barriers

Request for Sample PDF Report for Postoperative Pain Pipeline Assessment and clinical trials- https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1
Postoperative Pain Report Introduction
2
Postoperative Pain Executive Summary
3
Postoperative Pain Overview
4
Postoperative Pain- Analytical Perspective In-depth Commercial Assessment
5
Postoperative Pain Pipeline Therapeutics
6
Postoperative Pain Late Stage Products (Phase II/III)
7
Postoperative Pain Mid Stage Products (Phase II)
8
Postoperative Pain Early Stage Products (Phase I)
9
Postoperative Pain Preclinical Stage Products
10
Postoperative Pain Therapeutics Assessment
11
Postoperative Pain Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Postoperative Pain Key Companies
14
Postoperative Pain Key Products
15
Postoperative Pain Unmet Needs
16
Postoperative Pain Market Drivers and Barriers
17
Postoperative Pain Future Perspectives and Conclusion
18
Postoperative Pain Analyst Views
19
Appendix
20
About DelveInsight

Download Sample PDF Report to know more about Postoperative Pain drugs and therapies- https://www.delveinsight.com/sample-request/postoperative-pain-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Related Reports:

Postoperative Pain Market https://www.delveinsight.com/report-store/postoperative-pain-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Postoperative Pain-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Postoperative Pain Epidemiology https://www.delveinsight.com/report-store/postoperative-pain-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Postoperative Pain Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"DelveInsight's 'Ventricular Assist Devices (VAD) Market Insight, Competitive Landscape and Market Forecast - 2027' report delivers an in-depth understanding of Ventricular Assist Devices and the historical and forecasted Ventricular Assist Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.
Vein Illumination Devices Market https://www.delveinsight.com/report-store/vein-illumination-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's 'Vein Illumination Devices - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Basal Cell Carcinoma (Basal Cell Epithelioma) Market
https://www.delveinsight.com/report-store/basal-cell-carcinoma-basal-cell-epithelioma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

DelveInsight's "Basal Cell Carcinoma (Basal Cell Epithelioma) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Basal Cell Carcinoma (Basal Cell Epithelioma), historical and forecasted epidemiology as well as the Basal Cell Carcinoma (Basal Cell Epithelioma) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Media Contact

Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postoperative Pain Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments here

News-ID: 2801835 • Views:

More Releases from DelveInsight Business Research

Global Pharmaceutical Cartridges Market to grow at a CAGR of 7.39% to reach USD 2,693.14 million by 2032, Evaluates DelveInsight
Global Pharmaceutical Cartridges Market to grow at a CAGR of 7.39% to reach USD …
According to DelveInsight's analysis, The growth of the pharmaceutical cartridges market is largely fueled by the increasing prevalence of chronic diseases that require long-term and consistent medication use. Moreover, the rising trend of self-administered treatments and the growing preference for home-based healthcare are major contributors to market expansion. Technological advancements in drug delivery systems have further supported this growth by enhancing patient convenience, improving dosage precision, and promoting better treatment
Global Nucleic Acid Amplification Testing Market to grow at a CAGR of 8.13% by 2032, Evaluates DelveInsight
Global Nucleic Acid Amplification Testing Market to grow at a CAGR of 8.13% by 2 …
According to DelveInsight's analysis, The growing demand for Nucleic Acid Amplification Testing (NAAT) is primarily driven by the increasing prevalence of infectious and genetic diseases. Additionally, the rising incidence of cancer and the expanding R&D efforts by major industry players are further fueling market growth. Together, these factors are expected to support a strong upward trajectory for the NAAT market throughout the forecast period from 2025 to 2032. DelveInsight's "Nucleic Acid
Global Cardiac Mapping System Market to grow at a CAGR of 8.37% by 2032, Evaluates DelveInsight
Global Cardiac Mapping System Market to grow at a CAGR of 8.37% by 2032, Evaluat …
According to DelveInsight's analysis, The growing incidence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is driving the expansion of the cardiac mapping system market. These systems play a crucial role in the early detection and management of such conditions by providing real-time visualization of the heart's electrical activity, thereby reducing the risk of severe complications like stroke and heart failure. Moreover, the rising adoption of minimally invasive procedures,
Global Graft Preparation System Market to grow at a CAGR of 4.17% to reach USD 3.15 billion by 2032, Evaluates DelveInsight
Global Graft Preparation System Market to grow at a CAGR of 4.17% to reach USD 3 …
According to DelveInsight's analysis, The demand for graft preparation systems is experiencing notable growth, primarily driven by the rising incidence of bone disorders and skin-related conditions. Moreover, the increasing number of surgical procedures worldwide, coupled with expanding R&D initiatives and strategic collaborations among leading market players, is further fueling market expansion. Together, these factors are expected to create a strong growth outlook for the graft preparation system market during the

All 5 Releases


More Releases for Postoperative

Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative acute pain (POAP) remains one of the most significant challenges in clinical care, affecting nearly 80% of patients after surgery. Poorly managed pain can lead to complications such as delayed recovery, prolonged hospital stays, readmissions, and higher healthcare costs. Traditionally, opioid analgesics have been the cornerstone of treatment, but rising concerns around opioid dependency and adverse effects are fueling demand for safer, multimodal pain management approaches. Download Full PDF Sample
Postoperative Pain Therapeutics Market Innovations and Trends for 2032
The Postoperative Pain Therapeutics market has become an essential sector within the healthcare industry, particularly in the wake of increasing surgical procedures and the subsequent need for effective pain management solutions. This market encompasses a wide range of therapeutics designed to alleviate pain following surgical interventions, ensuring patient comfort and satisfaction during recovery. With a focus on improving patient outcomes, the postoperative pain therapeutics market has seen significant advancements, driven
Postoperative Pain Therapeutics Market Analysis and Forecast (2024-2032)
The introduction serves as the foundational section of our analysis. It aims to provide a comprehensive overview of the Postoperative Pain Therapeutics Market, emphasizing its significance and the purpose of the analysis. The Postoperative Pain Therapeutics Market plays a pivotal role in the healthcare industry. It addresses the critical need for effective pain management following surgical procedures, contributing to patient comfort and recovery. This market has witnessed substantial growth due to
Postoperative Pain Therapeutics Market: An In-Depth Analysis
In the ever-evolving landscape of healthcare, the Postoperative Pain Therapeutics Market has emerged as a significant player. This market, valued at USD 0.88 billion in 2023, is driven by various factors such as the production and commercialization of new drugs, increased research and development activities, rising health concerns, enhanced diagnostics facilities, and a growing global population. With a projected compound annual growth rate (CAGR) of 9.3% between 2024 and 2032,
Postoperative Nausea and Vomiting Management Market Rising focus on patient comf …
Global Postoperative Nausea and Vomiting Management Market Overview: The Postoperative Nausea and Vomiting Management market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others. In recent years, the Postoperative Nausea and Vomiting Management market has experienced significant growth, driven by factors such as increasing consumer demand,
Prevention and management of postoperative endophthalmitis
The decisive criterion of postoperative endophthalmitis after cataract operations or intravitreal injections is the contamination of the operating area and the instruments / implants with pathogens during the surgical procedure. In traditional operating theaters, the "sterility" is very limited and only given directly under the supply air ceiling. However, the surgical field is almost completely shielded from the ultra-clean air by the surgical microscope and the surgeon's head, so that